Search clinical trials for: relapsed multiple myeloma
Total 17201 results
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
CASI Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited Kingdom, France
-
Multiple Myeloma Research FoundationActive, not recruiting
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisActive, not recruiting
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingFollicular Lymphoma | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Bone Marrow Failure Syndromes | Burkitt's Lymphoma | Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Cellectar Biosciences, Inc.CompletedMultiple MyelomaUnited States
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
AbbVieJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, Denmark, France, Germany, Japan
-
AbbVieActive, not recruiting
-
Ohio State University Comprehensive Cancer CenterCureTech LtdTerminatedMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Karyopharm Therapeutics IncWithdrawn
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
Virginia Commonwealth UniversityMassey Cancer CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Recurrent Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Plasma... and other conditionsUnited States
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryFrance
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Genentech, Inc.Seagen Inc.Completed
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
Janssen Research & Development, LLCCompleted
-
Jennifer AmengualCompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Oncopeptides ABPrecision For MedicineCompletedMultiple MyelomaSpain, United States, France, Italy
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Prelude TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Non Hodgkin LymphomaUnited States
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple Myeloma
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
ChimerixActive, not recruiting
-
Bristol-Myers SquibbAbbVie; CelgeneCompletedMultiple MyelomaUnited States, Germany, Italy, Greece, Netherlands, Australia, Spain, Poland, Canada, France, Japan
-
CelgeneCompletedMultiple MyelomaBelgium, United Kingdom, Italy, Germany, Sweden, Denmark, Norway, Spain
-
AmgenWithdrawnRelapsed/Refractory Multiple Myeloma
-
TakedaCompleted
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Gadeta B.V.Active, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
Johnson & Johnson Private LimitedCompleted
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
PETHEMA FoundationCelgene Corporation; Array BioPharmaCompleted
-
Ciusss de L'Est de l'Île de MontréalCelgene; C3i Center Inc.Active, not recruitingMultiple Myeloma | Relapsed Hematologic MalignancyCanada
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States